Journal: bioRxiv
Article Title: Spatiotemporal profiling reveals the role of inflammatory niche in driving prostate cancer
doi: 10.64898/2026.04.19.719485
Figure Lengend Snippet: A, Experimental workflow for generating and assaying prostate organoid morphology. B, TKO organoids are more resistant to an AR degrader. Viability (y axis) of control (NTC, left) and TKO (right) organoids at different concentrations (x axis) of an AR degrader. IC50 values are shown at bottom left. C,D, Cell state heterogeneity in TKO organoids. C, UMAP embeddings of scRNA-seq profiles (dots) of NTC and TKO cells (as in ) colored by gene module scores. D, Fraction of cells (right) with top score for each gene module in control (NTC) and TKO organoids (x axis). Right: Enriched top GO terms (FDR<0.05 as in ) in each module. E, Neoantigen and GFP expression in NINJA prostate organoids. Flow cytometry plots of percentage of cells expressing GFP, in-frame with neoantigens, in NINJA prostate organoids without CRE recombinase (CRE), doxycycline, and tamoxifen (left), with CRE but without doxycycline and tamoxifen (middle), and with CRE, doxycycline and tamoxifen for 72 hours (right). F , Experimental mouse model. TKO organoids from NINJA mice treated with doxycycline and tamoxifen pre-transplantation were transplanted into immunocompetent (C57BL/6, n=10) and immunodeficient (NSG, n=10) mice. G,H CD8 T cell infiltration. G, (Left) Workflow. Right: Representative flow cytometry plots from stained (left) and unstained (right) samples, gated for CD8a, MHC class I tetramer (for neoantigen-specific T cells), and PD1 expression. H, Percentage (y axis) of neoantigen-specific (tetramer-positive, left) and PD1-positive CD8+ T cells (right), at 6- and 12-weeks post-transplantation with castration (x axis). Dots: individual mice. I , Prostates from different experimental groups.
Article Snippet: For in vitro delivery of CRE recombinase, Takara’s CRE recombinase gesicles (Takara Bio USA, (Catalog No. 631449) were used according to the manufacturer’s instructions.
Techniques: Control, Expressing, Flow Cytometry, Immunopeptidomics, Transplantation Assay, Staining